Compare HCA Health Inc (HCA) vs Visa Inc (V) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Visa Inc — how do they compare? HCA Health Inc trades at $371.96 (market cap $82.17B), while Visa Inc trades at $359.17 (market cap $685.71B). The key difference: Visa Inc is far larger — about 8.3× HCA Health Inc's market cap, and HCA Health Inc pays the higher dividend (0.84%). Which is the better fit depends on your goals.
| HCA | V | |
|---|---|---|
Market Cap | $82.17B | $685.71B |
Sector | Health | Financials |
52-Week High | $545.13 | $365.14 |
52-Week Low | $334.32 | $295.52 |
Enterprise Value | $131.08B | $696.30B |
Dividend Yield | 0.84% | 0.74% |
Volume | — | 10,431,336 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare trades at $370.74, down 0.12% on the day, with a bearish technical signal but strong fundamentals including consistent earnings beats and revenue growth to $75.6 billion in 2025. The stock faces headwinds from lowered 2026 guidance and negative news flow, but maintains a solid valuation with a P/E of 12.79 and positive analyst consensus.
The outlook is mixed: attractive valuation and operational strength support upside to the $469.40 price target, but near-term risks from payer mix shifts and legal investigations warrant caution. Long-term growth drivers include capacity expansion and medical advancements, though investor sentiment is currently pressured.
Visa (V) trades at $358.56, down 1.8% on the day, but maintains strong technical momentum with bullish moving averages and key support at $357. The company continues to deliver impressive financial performance with Q1 2026 EPS beating expectations at $3.31 versus $3.10, maintaining high profitability margins above 50%. Recent developments include the launch of Intelligent Commerce Connect for AI-powered commerce and expanded stablecoin partnerships.
With 85% analyst buy ratings and a $396.70 consensus price target suggesting 11% upside, Visa presents a compelling long-term investment opportunity. However, investors should monitor rising fintech competition and regulatory pressures that could impact the payment processing landscape. The company's consistent earnings beats and strong cash flow generation support continued dividend growth and shareholder returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →
